4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor

被引:14
|
作者
Jayasekara, P. Suresh [1 ]
Barrett, Matthew O. [2 ]
Ball, Christopher B. [2 ]
Brown, Kyle A. [2 ]
Kozma, Eszter [1 ]
Costanzi, Stefano [3 ]
Squarcialupi, Lucia [1 ]
Balasubramanian, Ramachandran [1 ]
Maruoka, Hiroshi [1 ]
Jacobson, Kenneth A. [1 ]
机构
[1] Natl Inst Diabet & Digest & Kidney Dis, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
[2] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[3] American Univ, Dept Chem, Washington, DC 20016 USA
关键词
A(3) ADENOSINE RECEPTOR; SELECTIVE AGONISTS; FLOW-CYTOMETRY; FLUORESCENT; DESENSITIZATION; MUTAGENESIS; ACTIVATION; ANALOGS; CELLS; UDP;
D O I
10.1039/c3md00132f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-Alkyloxyimino derivatives of pyrimidine nucleotides display high potency as agonists of certain G protein-coupled P2Y receptors (P2YRs). In an effort to functionalize a P2Y(6)R agonist for fluorescent labeling, we probed two positions (N-4 and gamma-phosphate of cytidine derivatives) with various functional groups, including alkynes for click chemistry. Functionalization of extended imino substituents at the 4 position of the pyrimidine nucleobase of CDP preserved P2Y(6)R potency generally better than gamma-phosphoester formation in CTP derivatives. Fluorescent Alexa Fluor 488 conjugate 16 activated the human P2Y(6)R expressed in 1321N1 human astrocytoma cells with an EC50 of 9 nM, and exhibited high selectivity for this receptor over other uridine nucleotide-activated P2Y receptors. Flow cytometry detected specific labeling with 16 to P2Y(6)R-expressing but not to wild-type 1321N1 cells. Additionally, confocal microscopy indicated both internalized 16 (t(1/2) of 18 min) and surface-bound fluorescence. Known P2Y(6)R ligands inhibited labeling. Theoretical docking of 16 to a homology model of the P2Y(6)R predicted electrostatic interactions between the fluorophore and extracellular portion of TM3. Thus, we have identified the N-4-benzyloxy group as a structurally permissive site for synthesis of functionalized congeners leading to high affinity molecular probes for studying the P2Y(6)R.
引用
收藏
页码:1156 / 1165
页数:10
相关论文
共 50 条
  • [1] 4-Alkyloxyimino Derivatives of Uridine-5′-triphosphate: Distal Modification of Potent Agonists as a Strategy for Molecular Probes of P2Y2, P2Y4, and P2Y6 Receptors
    Jayasekara, P. Suresh
    Barrett, Matthew O.
    Ball, Christopher B.
    Brown, Kyle A.
    Hammes, Eva
    Balasubramanian, Ramachandran
    Harden, T. Kendall
    Jacobson, Kenneth A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (09) : 3874 - 3883
  • [2] Pyrimidine Nucleotides with 4-Alkyloxyimino and Terminal Tetraphosphate δ-Ester Modifications as Selective Agonists of the P2Y4 Receptor
    Maruoka, Hiroshi
    Jayasekara, M. P. Suresh
    Barrett, Matthew O.
    Franklin, Derek A.
    de Castro, Sonia
    Kim, Nathaniel
    Costanzi, Stefano
    Harden, T. Kendall
    Jacobson, Kenneth A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (12) : 4018 - 4033
  • [3] Pyrimidine Ribonucleotides with Enhanced Selectivity as P2Y6 Receptor Agonists: Novel 4-Alkyloxyimino, (S)-Methanocarba, and 5′-Triphosphate γ-Ester Modifications
    Maruoka, Hiroshi
    Barrett, Matthew O.
    Ko, Hyojin
    Tosh, Dilip K.
    Melman, Artem
    Burianek, Lauren E.
    Balasubramanian, Ramachandran
    Berk, Barkin
    Costanzi, Stefano
    Harden, T. Kendall
    Jacobson, Kenneth A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (11) : 4488 - 4501
  • [4] The P2Y6 Receptor Stimulates Bone Resorption by Osteoclasts
    Orriss, Isabel R.
    Wang, Ning
    Burnstock, Geoffrey
    Arnett, Timothy R.
    Gartland, Alison
    Robaye, Bernard
    Boeynaems, Jean-Marie
    ENDOCRINOLOGY, 2011, 152 (10) : 3706 - 3716
  • [5] The role of P2Y6 receptor in the pathogenesis of cardiovascular and inflammatory diseases
    Nishiyama, Kazuhiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2024, 154 (02) : 108 - 112
  • [6] Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists
    Ko, Hyojin
    Carter, Rhonda L.
    Cosyn, Liesbet
    Petrelli, Riccardo
    de Castro, Sonia
    Besada, Pedro
    Zhou, Yixing
    Cappellacci, Loredana
    Franchetti, Palmarisa
    Grifantini, Mario
    Van Calenbergh, Serge
    Harden, T. Kendall
    Jacobson, Kenneth A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (12) : 6319 - 6332
  • [7] Pyrimidine nucleotides containing a (S)-methanocarba ring as P2Y6 receptor agonists
    Toti, Kiran S.
    Jain, Shanu
    Ciancetta, Antonella
    Balasubramanian, Ramachandran
    Chakraborty, Saibal
    Surujdin, Ryan
    Shi, Zhen-Dan
    Jacobson, Kenneth A.
    MEDCHEMCOMM, 2017, 8 (10) : 1897 - 1908
  • [8] Structure-activity relationships of pyrimidine nucleotides containing a 5′-α,β-methylene diphosphonate at the P2Y6 receptor
    Oliva, Paola
    Scortichini, Mirko
    Dobelmann, Clemens
    Jain, Shanu
    Gopinatth, Varun
    Toti, Kiran S.
    Phung, Ngan B.
    Junker, Anna
    Jacobson, Kenneth A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 45
  • [9] Lack of specificity shown by P2Y6 receptor antibodies
    Yu, Weiqun
    Hill, Warren G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 (10) : 885 - 891
  • [10] The P2Y6 Receptor as a Potential Keystone in Essential Hypertension
    Daghbouche-Rubio, Nuria
    Alvarez-Miguel, Ines
    Flores, Victor Alejandro
    Rojo-Mencia, Jorge
    Navedo, Manuel
    Nieves-Citron, Madeleine
    Cidad, Pilar
    Perez-Garcia, M. Teresa
    Lopez-Lopez, Jose R.
    FUNCTION, 2024, 5 (06):